SEER

Seer, Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$1.93

−$0.01−0.52%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

Aug 12, 2026$1.93

−$0.21−9.81%over 1M

Day range0% of range

$1.93$1.97

Session

Previous close: $1.94
Open: $1.94
Volume: 152.53K
Avg volume: -
Day high: $1.97
Day low: $1.93

Fundamentals

Visualize fundamentals and more

Market cap: -
P/E ratio: -
EPS (TTM): -
Dividend yield: -
Beta: 1.48
Shares outstanding: -

Source SEC EDGAR · 9/11/2026

Risk factors, year on year

Item 1AMarch 2026 10-KMarch 2025as filed.

added: 11
dropped: 12
re-drafted: 48

Out of 288 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

• our ability to successfully grow revenue generated from sales of the Proteograph Product Suite on our anticipated timeline;

22 more passages, included withBespoke

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

Litigation
FDA approval
Patent expiry
Key people
Cybersecurity
Tariffs
Data privacy
China

And 15 more.

Litigation
Distributors may not properly maintain or defend our intellectual property rights or may use our intellectual property, and our confidential or proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual …

7 more themes, included withMeasure

Recent activity

27 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Seer, Inc.

Also filed under Biotechnology, ranked by how closely they sit beside SEER.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
NVONOVO NORDISK A S
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc

Ask about Seer, Inc.

The assistant answers from what SEER has actually filed: 6 annual reports filed with the SEC and 1 fund that holds it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from SEER's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Seer, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Seer, Inc.

Separate the decisions from the paperwork
Every Form 4 SEER insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Seer, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.